InMode (INMD) Fundamentals 2026 — P/E 11.1x, Revenue Analysis | SniperIQ
InMode (INMD) is a IL-listed Healthcare company in Medical - Devices with a market capitalization of $879M, trading at
InMode (INMD) is a IL-listed Healthcare company in Medical - Devices with a market capitalization of $879M, trading at
InMode (INMD) has a market capitalization of approximately $879M, trading at
InMode's trailing twelve-month P/E ratio is 11.1x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
InMode runs a net profit margin of 23.3%, a gross margin of 77.8%, and an operating margin of 21.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
InMode reported revenue of
InMode does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
InMode carries a debt-to-equity ratio of 0.01x and a current ratio of 8.80x, with a market beta of 1.91. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For InMode (INMD) the key facts are: market cap $879M, P/E 11.1x, revenue
Get InMode's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.